It has been shown that TAMs serve as a source of key components in the inflammatory microenvironment, such as MFG-E8 and IL-6, in non-small-cell lung carcinoma (NSCLC) that trigger tumorigenicity and resistance to anticancer therapeutics by regulating CSCs activities [33]. This evidence concerns the gene IL6 and non-small cell lung carcinoma.